Cutaneous sıde-effects of the potential COVID-19 drugs.

Ümit Türsen Belma Türsen Torello M Lotti

Published in: Dermatologic therapy (2020)

COVID-19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon-beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side-effects of these drugs.

Keyphrases

coronavirus disease
sars cov
human health
drug induced
clinical trial
randomized controlled trial
risk assessment
respiratory syndrome coronavirus
immune response
climate change